Company performance
Add to research
Current Price
as of Apr 21, 2025$6.01
P/E Ratio
N/A
Market Cap
$966.67M
Description
Add to research
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Metrics
Add to research
Overview
- HQGaithersburg, MD
- SectorHealth Technology
- IndustryBiotechnology
- TickerNVAX
- Price$6.01+0.17%
Trading Information
- Market cap$966.67M
- Float91.13%
- Average Daily Volume (1m)5,958,034
- Average Daily Volume (3m)4,775,917
- EPS-$1.23
Company
- Revenue$682.16M
- Rev growth (1yr)-30.65%
- Net income-$187.50M
- Gross margin70.98%
- EBITDA margin-26.90%
- EBITDA-$183.47M
- EV$553.33M
- EV/Revenue0.81
- P/EN/A
- P/S1.34
- P/BN/A
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Wikipedia